Skip to main content
Top
Published in: Pediatric Rheumatology 1/2020

01-12-2020 | Systemic Lupus Erythematosus | Research article

Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus

Authors: Mona Dave, Judith Rankin, Mark Pearce, Helen E. Foster

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

Background

Musculoskeletal (MSK) conditions are a major source of morbidity and disability. There is a lack of global comparable data on the burden of MSK conditions in children and young people. Our aim was to estimate the global prevalence of three MSK conditions - Talipes Equinovarus (Clubfoot), Juvenile Idiopathic Arthritis (JIA) and Juvenile Systemic Lupus Erythematosus (JSLE).

Methods

Using reported prevalence rates, age-stratified population data within the World Bank Data Bank in 2017 and United Nations country classification, we estimated the prevalence of these MSK conditions in < 5 year olds (clubfoot) and < 16 year olds (JIA and JSLE) across the world.

Results

We estimated that in 2017, there were ~ 675,061 < 5 year olds with clubfoot among 675,100,000 < 5 year olds, ~ 2,069,246 < 16 year olds with JIA and ~ 206,931 < 16 year olds with JSLE per 2,069,000,000 < 16 year olds, totalling ~ 2,951,238 with one of these conditions. Disease prevalence was greatest in Asia (South Asia), followed by Africa, Americas, Europe and Oceania.

Conclusions

An estimated 3 million children and young people globally are currently living with either clubfoot, JIA or JSLE; many in Asia and Africa. Further work is needed urgently to engage with global stakeholders to work together to improve access to effective care for the many who are affected and reduce the otherwise adverse lifelong impact on their health, quality of life and the impact on society.
Appendix
Available only for authorised users
Literature
1.
go back to reference James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef
2.
go back to reference Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy DG, Kopansky-Giles D, et al. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018;96(5):366.CrossRef Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy DG, Kopansky-Giles D, et al. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018;96(5):366.CrossRef
3.
go back to reference Clark P, Ellis B. A public health approach to musculoskeletal health. Best Pract Res Clin Rheumatol. 2014;28(3):517–32.CrossRef Clark P, Ellis B. A public health approach to musculoskeletal health. Best Pract Res Clin Rheumatol. 2014;28(3):517–32.CrossRef
4.
go back to reference Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database. Ann Rheum Dis. 2019;78(6):844–8.CrossRef Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database. Ann Rheum Dis. 2019;78(6):844–8.CrossRef
6.
go back to reference Tan A, Strauss VY, Protheroe J, Dunn KM. Epidemiology of paediatric presentations with musculoskeletal problems in primary care. BMC Musculoskelet Disord. 2018;19(1):40.CrossRef Tan A, Strauss VY, Protheroe J, Dunn KM. Epidemiology of paediatric presentations with musculoskeletal problems in primary care. BMC Musculoskelet Disord. 2018;19(1):40.CrossRef
8.
go back to reference Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. PLoS One. 2018;13(4):e0194986.CrossRef Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. PLoS One. 2018;13(4):e0194986.CrossRef
9.
go back to reference Werler MM, Yazdy MM, Mitchell AA, Meyer RE, Druschel CM, Anderka M, et al. Descriptive epidemiology of idiopathic clubfoot. Am J Med Genet A. 2013;161(7):1569–78.CrossRef Werler MM, Yazdy MM, Mitchell AA, Meyer RE, Druschel CM, Anderka M, et al. Descriptive epidemiology of idiopathic clubfoot. Am J Med Genet A. 2013;161(7):1569–78.CrossRef
10.
go back to reference Bridgens J, Kiely N. Current management of clubfoot (congenital talipes equinovarus). BMJ. 2010;340:c355.CrossRef Bridgens J, Kiely N. Current management of clubfoot (congenital talipes equinovarus). BMJ. 2010;340:c355.CrossRef
11.
go back to reference Grimes CE, Holmer H, Maraka J, Ayana B, Hansen L, Lavy CB. Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method. BMJ Glob Health. 2016;1(1):e000023.CrossRef Grimes CE, Holmer H, Maraka J, Ayana B, Hansen L, Lavy CB. Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method. BMJ Glob Health. 2016;1(1):e000023.CrossRef
12.
go back to reference Alavi Y, Jumbe V, Hartley S, Smith S, Lamping D, Muhit M, et al. Indignity, exclusion, pain and hunger: the impact of musculoskeletal impairments in the lives of children in Malawi. Disabil Rehabil. 2012;34(20):1736–46.CrossRef Alavi Y, Jumbe V, Hartley S, Smith S, Lamping D, Muhit M, et al. Indignity, exclusion, pain and hunger: the impact of musculoskeletal impairments in the lives of children in Malawi. Disabil Rehabil. 2012;34(20):1736–46.CrossRef
13.
go back to reference Ruperto N, Martini A. Current and future perspectives in the management of juvenile idiopathic arthritis. Lancet Child Adolesc Health. 2018;2(5):360–70.CrossRef Ruperto N, Martini A. Current and future perspectives in the management of juvenile idiopathic arthritis. Lancet Child Adolesc Health. 2018;2(5):360–70.CrossRef
14.
go back to reference Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207.CrossRef Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207.CrossRef
15.
go back to reference Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112–7.CrossRef Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112–7.CrossRef
16.
go back to reference Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–63.CrossRef Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–63.CrossRef
17.
go back to reference Saurenmann R, Rose J, Tyrrell P, Feldman B, Laxer R, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–84.CrossRef Saurenmann R, Rose J, Tyrrell P, Feldman B, Laxer R, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–84.CrossRef
18.
go back to reference Sawhney S, Manners P. The place of pediatric rheumatology in India. Indian J Pediatr. 2010;77(9):993–6.CrossRef Sawhney S, Manners P. The place of pediatric rheumatology in India. Indian J Pediatr. 2010;77(9):993–6.CrossRef
19.
go back to reference Manners PJ. Epidemiology of the rheumatic diseases of childhood. Curr Rheumatol Rep. 2003;5(6):453–7.CrossRef Manners PJ. Epidemiology of the rheumatic diseases of childhood. Curr Rheumatol Rep. 2003;5(6):453–7.CrossRef
20.
go back to reference Berntson L, Gäre BA, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30(10):2275–82.PubMed Berntson L, Gäre BA, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30(10):2275–82.PubMed
21.
go back to reference Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol. 2009;36(11):2539–46.CrossRef Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol. 2009;36(11):2539–46.CrossRef
22.
go back to reference Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64(8):2669–76.CrossRef Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64(8):2669–76.CrossRef
23.
go back to reference Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6(9):538.CrossRef Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6(9):538.CrossRef
24.
go back to reference Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556–62.CrossRef Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556–62.CrossRef
25.
go back to reference Huang J, Yeh K, Yao T, Huang Y, Chung H, Ou L, et al. Pediatric lupus in Asia. Lupus. 2010;19(12):1414–8.CrossRef Huang J, Yeh K, Yao T, Huang Y, Chung H, Ou L, et al. Pediatric lupus in Asia. Lupus. 2010;19(12):1414–8.CrossRef
26.
go back to reference Spittal GW, Lewandowski LB, Scott C. A clinical update on paediatric lupus. S Afr Med J. 2015;105(12):1075.CrossRef Spittal GW, Lewandowski LB, Scott C. A clinical update on paediatric lupus. S Afr Med J. 2015;105(12):1075.CrossRef
27.
go back to reference Pineles D, Valente A, Warren B, Peterson M, Lehman T, Moorthy L. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20(11):1187–92.CrossRef Pineles D, Valente A, Warren B, Peterson M, Lehman T, Moorthy L. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20(11):1187–92.CrossRef
29.
go back to reference Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, et al. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind. Clin Rheumatol. 2019;38(2):563–75.CrossRef Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, et al. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind. Clin Rheumatol. 2019;38(2):563–75.CrossRef
31.
go back to reference Bhutani J, Bhutani S. Worldwide burden of diabetes. Indian J Endocrinol Metab. 2014;18(6):868.CrossRef Bhutani J, Bhutani S. Worldwide burden of diabetes. Indian J Endocrinol Metab. 2014;18(6):868.CrossRef
32.
go back to reference Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.CrossRef Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.CrossRef
33.
go back to reference Henrickson M. Policy challenges for the pediatric rheumatology workforce: Part III. the international situation. Pediatr Rheumatol. 2011;9(1):26.CrossRef Henrickson M. Policy challenges for the pediatric rheumatology workforce: Part III. the international situation. Pediatr Rheumatol. 2011;9(1):26.CrossRef
34.
go back to reference Arkachaisri T. Pediatric rheumatology in Southeast Asia: insights from the Singapore experience. Curr Rheumatol Rep. 2011;13(2):117–22.CrossRef Arkachaisri T. Pediatric rheumatology in Southeast Asia: insights from the Singapore experience. Curr Rheumatol Rep. 2011;13(2):117–22.CrossRef
35.
go back to reference Foster H, Rapley T. Access to pediatric rheumatology care -- a major challenge to improving outcome in juvenile idiopathic arthritis. J Rheumatol. 2010;37(11):2199–202.CrossRef Foster H, Rapley T. Access to pediatric rheumatology care -- a major challenge to improving outcome in juvenile idiopathic arthritis. J Rheumatol. 2010;37(11):2199–202.CrossRef
37.
go back to reference Symmons D, Jones M, Osborne J, Sills J, Southwood T, Woo P. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol. 1996;23(11):1975–80.PubMed Symmons D, Jones M, Osborne J, Sills J, Southwood T, Woo P. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol. 1996;23(11):1975–80.PubMed
38.
go back to reference Kocher MS, Bishop JA, Weed B, Hresko MT, Millis MB, Kim YJ, et al. Delay in diagnosis of slipped capital femoral epiphysis. Pediatrics. 2004;113(4):e322–e5.CrossRef Kocher MS, Bishop JA, Weed B, Hresko MT, Millis MB, Kim YJ, et al. Delay in diagnosis of slipped capital femoral epiphysis. Pediatrics. 2004;113(4):e322–e5.CrossRef
Metadata
Title
Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
Authors
Mona Dave
Judith Rankin
Mark Pearce
Helen E. Foster
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00443-8

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue